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Background/aim: Growth differentiation factor (GDF)-15 is related to inflammation and mortality in many conditions. We aimed to
determine if an elevated serum GDF-15 level is related to nutritional status of patients on hemodialysis (HD) and mortality.
Materials and methods: Routine HD patients (n = 158) were included in the study and followed for 18 months. Some malnutrition/
inflammation scoring indexes (malnutrition/inflammation score (MIS), controlling nutritional status (CONUT) score, and prognostic
nutritional index (PNI)), biochemical parameters, and GDF-15 were used to build Cox regression multivariate models to study the
association with mortality.
Results: Among the patients, 90 (57 %) had a high MIS (≥8), which associates with worse status. The serum GDF-15 level was higher
in the same group (p = 0.003). The serum GDF-15 level differentiated malnutrition/inflammation according to the MIS (p = 0.031).
Age, GDF15, and C-reactive protein (CRP) were significantly associated with higher all-cause mortality risk. Patients with both age and
GDF-15 above the mean had a hazard ratio of 2.76 (p = 0.006) when compared with those both < mean.
Conclusion: In HD patients, the GDF-15 level is increased in worse nutritional status. Beyond the MIS, age, GDF-15 and CRP would
be used together to estimate the worse clinical outcome in these patients.
Key words: Malnutrition, nutrition, hemodialysis, growth differentiation factor-15, malnutrition/inflammation score (MIS)

1. Introduction
Growth differentiation factor-15 (GDF-15) is a TGF-β
superfamily member and is widely expressed in
mammalian tissues [1]. An elevated serum GDF-15 level
is associated with numerous pathological conditions.
Cardiovascular diseases [2], ineffective erythropoiesis
[3], such chronic diseases as rheumatoid arthritis, endstage renal failure, and diabetes [1], and many cancers
[4] are associated with a high GDF-15 level. Notably, in
cancer patients, overexpressed GDF-15 was identified
as a novel appetite regulator that causes anorexia and
weight loss [5]. Weight loss, protein-energy wasting, and
malnutrition/inflammation are the strongest predictors
of over-all mortality in hemodialysis (HD) patients [6–8].
Some studies have examined the prognostic significance
of GDF-15 in HD patients [9], but findings related to
the correlation between GDF-15 and the severity of
malnutrition/inflammation is inconsistent. Thus, the

present study aimed to determine if there is an association
between the GDF-15 level and nutrition parameters
and malnutrition/inflammation scoring indexes in HD
patients. An additional aim was to differentiate mortality
according to HD patients’ malnutrition scores and serum
GDF-15 levels.
2. Materials and methods
2.1. Study design
This prospective observational study included patients with
end-stage renal disease (ESRD) that were on conventional
maintenance HD in our outpatient dialysis center. Patients
were followed-up for 18 months. Inclusion criteria were
as follows: being >18 years and undergoing HD for ≥4 h
per session, ≥3 times per week, and for ≥12 months. To
minimize confounding of inflammatory biomarkers,
patients with active infection and those with a central
venous catheter for vascular access during the previous
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12 months were excluded. Patients with a history of any
malignancy, inflammatory disease, or immunosuppressive
drug usage were also excluded. To facilitate unbiased
serum GDF-15 analysis patients with acute thrombosis or
acute cardiovascular conditions (including acute coronary
syndrome or acute heart failure) during the previous 12
months, known heart failure or an ejection fraction (EF)
<55% were also excluded. Other exclusion criteria were
being unwillingness to participate in the study and having
a history of coronary artery bypass surgery. The study
included 158 of 379 patients that met the inclusion criteria.
2.2. Data collection
All patients were assessed in terms of age, sex,
cigarette smoking, dialysis dose (single-pool Kt/V)
and vintage, comorbidities, body mass index (BMI),
electrocardiography findings, biochemical parameters,
malnutrition parameters, and malnutrition scores. Patients
that had not smoked cigarettes for the previous 12 months
were considered non-smokers.
Blood samples were obtained immediately before
the first midweek dialysis session of the month. Blood
specimens (8 mL) were collected into gel tubes for
GDF‑15, albumin, creatinine, blood urea nitrogen (BUN),
C-reactive protein (CRP), potassium, and total ironbinding capacity (TIBC) analysis. Serum samples were
centrifuged at 1200 g for 10 min at room temperature.
For GDF‑15 measurement, centrifuged samples were
aliquoted and then stored at −80 °C until analysis. The
serum GDF‑15 level was determined via an enzyme-linked
immunosorbent assay (ELISA; Cloud Clone, Houston,
TX, USA) using a spectrophotometer optical density
of 450 nm (Epoch, BioTek Instruments Inc., Winooski,
VT, USA), with intra- and inter-assay CVs of <10% and
<12%, respectively. The GDF-15 level was expressed as ng
mL−1. Creatinine, BUN, TIBC, and potassium levels were
measured using an Abbott Alinity c analyzer according to
the manufacturer’s instructions (Abbott Park, IL, USA).
EDTA whole- blood samples were used for complete
blood count (CBC). CBC analyses were completed within
1 h after venipuncture and performed using Abbott CELL
DYN Ruby hematology analyzer (Abbott Diagnostics,
IL, USD). Hemoglobin, platelet, and white blood cells
(WBCs), including leukocyte differentials, were measured
as part of CBC. The platelet to lymphocyte ratio (PLR) and
neutrophil-lymphocyte ratio (NLR) values were calculated
using a related CBC parameter. Normalized protein
catabolic rate (nPCR) [10] and a nutritional risk index
(NRI) were calculated [11].
2.3. Malnutrition scores
The malnutrition-inflammation score (MIS) is a scoring
system and used to assess nutritional status quantitatively,
especially in HD patients [12]. The MIS consist of 4 parts,
10 components, each representing different aspects of

malnutrition-inflammation. Medical history of patient,
physical examination findings, BMI, and laboratory
parameters are the parts evaluated. And some of 10
components of the MIS have 4 levels of severity, ranging
from 0 (normal) to 4 (severely abnormal). The sum of
all components ranges from 0 (normal) to 30 (severely
malnourished); higher scores indicate more severe
malnutrition-inflammation [13]. Patient medical history
includes dietary intake, weight changes, gastrointestinal
symptoms, functional capacity, and comorbidities. Physical
examination is performed to detect muscle wasting and
loss of subcutaneous fat. In laboratory assessment, serum
albumin and serum TIBC levels are measured. The MIS for
each patient was recorded at initiation of the study. Clinical
data, including age, sex, duration of dialysis, body weight
and height, and the presence of comorbid conditions were
obtained via the medical records. One of the investigators
evaluated all the patients to assess physical morbidity,
and subcutaneous muscle mass. After the assessment, the
patients were classified according to quartiles as follows:
quartile 1 (MIS 0–4 [n = 19]; quartile 2 (MIS 5–7 [n = 49]);
quartile 3 (MIS ≥ 8 [n = 90]). Kalantar-Zadeh et al. [12]
reported that the hazard ratio for death is almost 7-fold
higher in those with an MIS ≥8 than the <8 ones (adjusted
HR: 6.82; p < 0.001) [12]. As such, the present study
classified patients as low-risk of malnutrition (quartiles 1
and 2: score 0-7 [n = 68]) and high-risk of malnutrition
(quartile 3: score ≥8 [n = 90]).
The prognostic nutritional index (PNI) was calculated
as following: PNI = 10 × serum albumin concentration in
g dL−1 + 0.005 × total lymphocyte count per mm3. Patients
with a PNI >38 were considered normal, whereas those
with a PNI of 35–38 were considered to have a moderate
risk of malnutrition, and those with a PNI <35 were
considered to have a severe risk of malnutrition [14]. The
controlling nutritional status (CONUT) score consists
of serum albumin and total cholesterol levels, and the
total lymphocyte count. Patients with CONUT scores of
0–1 have a normal nutritional status, whereas those with
CONUT scores of 2–4 have a mild risk of malnutrition,
those with CONUT scores of 5–8 have a moderate risk of
malnutrition, and those with CONUT scores of 9–12 have
a severe risk of malnutrition [15].
2.4. Follow-up and end points
The HD patients were evaluated between March 2019 and
October 2020, and mortality was verified until October
2020 (for 18 months). None of the patients underwent
renal transplantation or were transferred to another
facility.
2.5. Statistical analysis
Categorical variables are presented as number and
percentage. Data with normal distribution are shown
as mean ± SD, and data not normally distributed are
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shown as median and interquartile range. For categorical
variables, the chi-square test was used. The independent
samples t-test or Mann–Whitney U test was used for
continuous variables. Variables with skewed distribution
were logarithmically (log) transformed before further
statistical analysis. Analysis of the correlation of each
parameter was performed using Pearson’s or Spearman’s
correlation coefficients. Results are given as correlation
coefficient (r) and p values.
Differentiation of patients that have malnutrition/
inflammation according to serum GDF-15 level was
performed using the area under a receiver operating
characteristic (AUROC) curve. The reference point was
accepted for MIS ≥ 8. AUROC was also made to determine
the cut-off value of GDF-15 to predict mortality at the end
of 18th month. An area under curve (AUC) of 0.5 indicates
no predictive ability, whereas a value of 1 represents
perfect predictive ability. Cut-off points were calculated by
obtaining the best Youden index.
The univariate Cox regression analysis was performed
to investigate the independence of risk factors associated
with all-cause mortality. If hazard ratios (HRs) for the
variables in the univariate analysis were significant, we
selected the covariates into the multivariable regression
model. GDF-15 was analyzed as a continuous variable.
A Kaplan–Meier curve censored for the high GDF-15
levels and MIS ≥ 8 events with a log-rank test served for
the cumulative recurrence rate of mortality at the end
of 18th month. The cumulative survival probability was
presented by graphical methods. Patients were further
cross-classified according to GDF-15 (mean = 49.5) and
age (mean = 63.3) in three groups: those with both GDF15 and age ≥ mean, those with both GDF-15 and age <
mean (reference category), and those with only one of age
or GDF-15 above the mean (age ≥ mean but not GDF-15
and GDF-15 ≥ mean but not age). Independent association
with mortality was also studied for this dummy-coded
variable.
The level of statistical significance was set at p < 0.05.
Data were analyzed using IBM SPSS Statistics for Windows
v.25.0 (IBM Corp., Armonk, NY, USA).
3. Results
Among the 158 patients that met the eligibility criteria, 60
(37.9 %) were female. Median age of the study population
was 66 years (19–87 years). The median (IQR) and range
of the serum GDF-15 values were 42.78 ng mL–1 (24.74–
65.25 ng mL–1), and 4.47–183.90 ng mL–1, respectively.
Mean MIS was 8.51 ± 3.40 for the entire study group. The
mean PNI was 38.11 ± 2.88, and 50% of the patients had
moderate to severe malnutrition (PNI ≤38). The median
CONUT score was 2 (0–7), and 51.9% of the patients
had mild to moderate malnutrition (CONUT score: 2-8).
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None of the patients were MIS quartile 4 or had a PNI <35
or CONUT score of 9-12, as such none of the patients had
severe malnutrition.
The study population was divided into 2 groups
regarding malnutrition/inflammation status according
to the MIS. In total, 68 (43%) of the patients had a low
MIS (quartiles 1 and 2; MIS score <8) and 90 (57%) had
a high MIS (quartile 3; MIS ≥8). The PNI was lower and
the CONUT score was higher in the patients with a high
MIS (p = 0.001 and p = 0.024, respectively). The serum
GDF-15 level was significantly higher in the patients with
a high MIS than in those with a low MIS (37.42 vs. 47.82,
p = 0.003). Logarithmic transformation of the GDF-15
data (logGDF-15) showed that the difference was still
significant according to parametric statistical tests. As
nutritional parameters, NRI and nPCR were also lower
in the patients with a high MIS (p = 0.023 and p = 0.001,
respectively). In addition, the serum albumin, serum
creatinine, and BUN levels were lower in the patients with
a high MIS. The inflammatory parameters CRP and NLR
were slightly higher in the patients with a high MIS, as well,
but only PLR was significantly higher (p = 0.021). In all,
18.9% (n = 30) of the patients died during the 18-month
follow-up period. Demographic data, laboratory results,
and nutritional parameters are summarized according to
low and high MIS in Table 1.
Based on correlation analysis of logGDF-15 with other
serum biomarkers of malnutrition/inflammation, there
was a negative correlation between the serum creatinine,
serum potassium, and serum albumin levels. Additionally,
logGDF-15 was positively correlated with CRP and
logarithmic transformation of age (logAge). There weren’t
any significant correlations between logGDF-15, and other
nutrition parameters or biochemical measurements. The
correlations data are summarized in Table 2.
Area under a receiver operating characteristic (AUROC)
was performed to explore the ability of the serum GDF-15
level to predict malnutrition according to the MIS, PNI,
and CONUT scores. The serum GDF-15 level significantly
differentiated malnutrition/inflammation according to
MIS (AUROC: 0.60; 95% CI: 0.512–0.689; p = 0.031). The
cutoff value for GDF-15 was 40.28 ng mL–1 with sensitivity
of 61% and specificity of 39% for predicting malnutrition
(Figure 1). AUROC curves for the ability of GDF-15 to
predict malnutrition according to the PNI and CONUT
score were not significant (AUROC: 0.428; 95% CI: 0.339–
0.517; p = 0.117 and AUC: 0.433; 95% CI: 0.344–0.523; p =
0.149, respectively).
Other AUROC curves were also performed to explore
the reference points for the Kaplan–Meier survival analysis
(Log Rank method) of the MIS and the serum GDF-15
levels to predict mortality after 18 months. The GDF-15
cutoff value was 49.3 ng mL–1, with sensitivity of 70%
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Table 1. Demographic findings, laboratory results and nutritional status findings of study group.
MIS Score < 8
(Quartile 1 and 2; n = 68)

MIS Score ≥ 8
(Quartile 3; n = 90)

Age (years)

63 (IQR:17) (Mean R:67.71)

69.50 (IQR:16) (Mean R:88.41) 0.005

Women (n)

23 (14.6%)

37 (23.4%)

0.409

Body mass index (kg/m )

26.71 ± 5.59

25.19 ± 5.40

0.086

Cigarette smoking (n)

13 (8.2 %)

17 (10.8 %)

0.564

Diabetes mellitus (n)

22 (13.9 %)

40 (25.3 %)

0.084

Coronary artery disease (n)

34 (21.5 %)

57 (36.1 %)

0.065

Hypertension (n)

58 (36.7 %)

77 (48.7 %)

0.569

Left ventricular hypertrophy (n)

60 (38.1 %)

83 (52.2 %)

0.282

Diastolic dysfunction (n)

48 (30.4 %)

76 (48.1 %)

0.029

Dialysis vintage (months)

36 (IQR:43) (Mean R:67.26)

63 (IQR:89) (Mean R:88.74)

0.003

Dialysis dose (Kt/V single pool)

1.54 ± 0.273

1.57 ± 0.262

0.425

Hemoglobin (g/dL)

11.54 ± 1.32

11.23 ± 1.22

0.132

Serum albumin (g/dL)

3.91 ± 0.23

3.72 ± 0.29

0.001

Serum creatinine (mg/dL)

8.86 ± 0.30

8.02 ± 0.23

0.026

BUN (mg/dL)

76.76 ± 17.80

67.13 ± 18.10

0.001

Serum potassium

5.10 ± 0.64

4,95 ± 0.69

0.172

Total iron binding capacity (mg/dL)

148.94 ± 47.90

131.34 ± 46.30

0.021

Total cholesterol (mg/dL)

173.12 ± 35.93

164.38 ± 37.37

0.141

C-reactive protein (mg/l)

18.56 ± 4.12

20.78 ± 3.27

0.674

NLR

3.177 ± 1,93

3.59 ± 3.03

0.297

PLR

126.10 ± 55.28

153.17 ± 89.50

0.021

nPCR (nPNA) (g.kg–1.day–1)

1.067 ± 0.239

0.978±0.235

0.001

NRI

100.69 ± 3.83

97.48 ± 4.32

0.023

PNI score

39.22 ± 2.33

37.26 ± 2.67

0.001

PNI score ≤ 38 (n)

20 (12.7 %)

59 (37.3 %)

0.001

CONUT score (Mild and moderate malnutrition; 2–8) (n)

28 (17.7%)
37.42 (IQR:33.54)
(Mean R:70.46)
1.58 ± 0.28

54 ± (34.2%)
47.82 (IQR:47.95)
(Mean R:86.33)
1.64 ± 0.30

0.024

8 (11.8 %)
16.50 (IQR:8)
(Mean R:17.50)

22 (24.4 %)
14.00 (IQR:4)
(Mean R:14.77)

0.034

p

Demographic

2

Biochemical measurements

Nutrition parameters

GDF-15 (ng/mL)
LogGDF-15
Death (n)
Time to death (months)

0.003
0.023
0.475

Results are presented as mean ± standard deviation (95% confidence interval) and median (IQR: interquartile range) for continuous
variables and n (%) for categorical variables. BUN: Blood urea nitrogen; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-tolymphocyte ratio; nPCR: normalized protein catabolic rate; NRI: nutrition risk index; PNI: prognostic nutritional index; CONUT:
The Controlling Nutritional Status; MIS: malnutrition-inflammation score; GDF-15: growth differentiation factor-15; logGDF-15:
logarithmically transformed Growth Differentiation Fcator-15; Mean R: mean rank.

and specificity of 39% for predicting mortality (AUROC:
0.709; 95% CI: 0.591–0.829; p = 0.003). The MIS cut-off
value was 8, with sensitivity of 73% and specificity of 53%

for predicting mortality (AUROC: 0.620; 95% CI: 0.5020.737; p = 0.042). Figure 2 and Figure 3 show the Kaplan–
Meier survival curves in patients with GDF-15 > 49.3
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Table 2. Correlation of laboratory tests and nutritional scores with logarithmically transformed
Growth Differentiation Factor-15.
r

p

r

p

logAge

0.222

0.005

BMI

0.094

0.242

nPCR

0.118

0.144

NRI

0.154

0.054

logDvintage

0.045

Serum albumin

–0.415

0.577

NLR

0.055

0.494

0.018

PLR

0.134

0.194

Serum creatinine
Serum potassium

–0.215

0.007

MIS

0.407

0.009

–0.207

0.009

PIN score

–0.191

0.016

C-reactive protein

0.183

0.021

CONUT Score

0.268

0.001

BMI: Body Mass Index; CONUT: The Controlling Nutritional Status; MIS: malnutritioninflammation score; logGDF-15: logarithmic transformation of growth differentiation factor-15;
logDvintage: logarithmic transformation of dialysis vintage; NLR: neutrophil-to-lymphocyte
ratio; PLR: platelet-to-lymphocyte ratio; PNI: prognostic nutritional index; logAge: logarithmic
transformation of age.
ROC Curve
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Figure 1. ROC curve from serum GDF-15 to predict malnutrition/inflammation
according to MIS

ng mL–1 and those with MIS ≥ 8 values. Kaplan–Meier
analysis showed a significantly lower event-free survival
time in the high GDF-15 group than the low GDF-15
group (17.6 months vs. 23.9 months, log rank p = 0.001,
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Figure 2). But the Kaplan–Meier analysis of event-free
survival time difference between high and low MIS was
not statistically different (17.5 months vs. 24.8 months, log
rank p = 0.064, Figure 3).
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Figure 2. The Kaplan-Meier survival curves to predict mortality after 18 months according
to serum GDF-15 level

Univariate and multivariate analysis results for allcause mortality are shown in Table 3. The variables entering
the univariate analysis were age, dialysis vintage, serum
albumin, C-reactive protein, serum creatinine, NLR, PLR,
nPCR (nPNA), serum GDF-15, MIS (MIS≥8), PNI score
(PNI >38), and CONUT score (2–8). In the multivariate
Cox regression, a final statistically significant Model-1 was
built with GDF-15, age, and C-reactive protein. Baseline
serum GDF-15 (HR 1.052, 95% CI 1.006–1.115, p =
0.001), age (HR 1.068, 95% CI 1.026-1.112, p = 0.001), and
C-reactive protein (HR 1.008, 95% CI 1.002–1.012, P =
0.049) were all independent predictors for 18th mortality.
To combine both age and GDF-15 affect in predicting
mortality, we created multivariate Cox regression Model-2.
Patients with both age and GDF-15 above the mean had
a HR of 18-month death of 2.76 (95% CI 1.37–5.02, p =
0.006) when compared with the reference category (both
age and GDF-15 below mean). Patients with only one of the
variables above the mean had a hazard ratio of 18-month
mortality of 1.16 (1.002–1.816, p = 0.02) when compared
with the reference category.

4. Discussion
The present study investigated the effectiveness of the serum
GDF-15 for predicting malnutrition and all-cause mortality,
as well as its correlation with nutrition/inflammation
laboratory measurements in HD patients. The findings
indicate that the serum GDF-15 level is useful for estimating
the nutritional status of HD patients when other scoring
systems are inconclusive. Assessment of the nutritional
status is a routine part of the care of maintenance HD
patients. Monthly dietary assessment, physical examination,
and laboratory examination is the primary method used
to estimate nutritional changes. MIS, originally developed
by Kalantar–Zadeh et al. [12], is a comprehensive tool for
assessing the nutritional and inflammatory status and is
associated with morbidity/mortality in HD patients. Newly
used scores like PNI and CONUT are also informative about
nutritional status of the patients [14,16]. However, none of
the current studies analyzed these scores and biochemical
parameters together. According to our findings, serum
GDF-15 level with MIS is stronger than PNI and CONUT to
estimate malnutrition in our HD patients.
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Figure 3. The Kaplan-Meier survival curves to predict mortality after 18 months according
to MIS

In the present study, patients with a high MIS
(≥8) were older and had a longer dialysis vintage than
those with a low MIS as expected. Moreover, the serum
albumin, serum creatinine, and BUN levels were lower in
the patients with a lower nutritional status. The catabolic
measurements nPCR and NRI were also lower in the
patients with a high MIS, which is in agreement with the
literature [11]. Inflammatory status assessment showed the
CRP and NLR were similar in the patients with a high and
low MIS, but that PLR was significantly higher in those
with a high MIS, which is in agreement with Turkmen et
al. [17]. They reported that PLR was superior to NLR for
assessing inflammation in ESRD patients. All biochemical
parameters directing worse nutritional and inflammatory
status was correlated with our high risk patient group
(MIS ≥ 8), highlighting the data related to malnutrition/
inflammation process in HD patients, as reported earlier
[18].
Other measures of malnutrition/inflammation,
including the PNI and CONUT scores were compatible
with the MIS. Some studies analyzed the PNI and CONUT
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score in HD patients, reporting that a lower PNI and higher
CONUT scores were correlated with poorer outcomes
[14, 19,20]. In mortality studies related to malnutrition/
inflammation in HD patients, the MIS was observed to be
a predictor of mortality and dialysis outcome [12,21]. The
PNI was independently associated with all-cause and CVD
mortality in peritoneal dialysis patients [19]. The CONUT
score was noted to be a clinical predictor of all-cause
mortality in peritoneal dialysis patients [20]. In our study,
the relationship between mortality and the MIS, PNI, and
CONUT scores were analyzed together. First, AUROC
curve analysis of GDF-15 level and MIS were significantly
correlated with mortality at the end of the 18th month of
follow-up. Nonetheless, the PNI and CONUT score did not
significantly differentiate mortality, perhaps because the
clinical assessment part of MIS makes the score stronger
than the PNI and CONUT score in HD patients. Second,
in the Kaplan–Meier survival analysis, it was documented
that patients with high GDF-15 serum levels had worse
event-free survival for 18 months. None of the scores
(MIS, PNI, CONUT) were associated with significant
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Table 3. Association of serum GDF-15 level and other variables with 18-month mortality: Univariate and multivariate
model of cox regression analysis.
Univariate Analysis

Multivariate Analysis

Tested variables

HR (95% CI)

p

HR (95% CI)

p

Age (years)

1.073 (1.033–1.113)

0.003

1.068 (1.026-1.112)

0.001

Dialysis vintage (months)

0.997 (0.992–1.003)

0.352

-

-

Serum albumin (g/dL)

0.242 (0.073–0.800)

0.020

-

-

C-reactive protein (mg/l)

1.009 (1.003–1.014)

0.002

1.008 (1.002-1.012)

0.049

Serum creatinine (mg/dL)

0.778 (0.668–0.907)

0.001

-

-

NLR

1.132 (1.040–1.232)

0.004

-

-

PLR

1.004 (1.001–1.008)

0.024

-

-

nPCR (nPNA) (g.kg–1.day–1)

0.268 (0.055–1.313)

0.104

-

-

GDF-15 (ng/mL)

1.019 (1.011–1.027)

<0.001

1.052 (1.006-1.115)

0.001

MIS (MIS ≥ 8)

2.119 (0.938–4.785)

0.071

-

-

PNI score (PNI >38)

0.419 (0.191–0.920)

0.063

-

-

CONUT score (2–8)

0.889 (0.427–1.848)

0.752

-

-

GDF-15: growth differentiation factor-15; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; nPCR:
normalized protein catabolic rate; PNI: prognostic nutritional index; CONUT: The Controlling Nutritional Status; MIS:
malnutrition-inflammation score.

outcomes. Third, in the univariate Cox regression analysis
of potential predictors, we did not find any significant
mortality-related estimation associated with MIS, PNI, or
CONUT scores. Since this time MIS was also excluded as
an estimator, GDF-15 became more valuable in the patients
with worse nutritional status. In the multivariate analysis,
final model was built with GDF-15, age, and CRP, which
were significant predictors of mortality. Three studies
analyzed GDF-15 and mortality in HD patients, and all
reported that a high GDF-15 level was associated with a
high risk of mortality [9,22,23]; however, none analyzed
the patients’ malnutrition/inflammation status. Breit et al.
[22] reported that, in a Swedish study population, a high
GDF-15 level was associated with poor nutrition status,
based on subjective global assessment questionnaires only.
Our study expands upon the existing literature on GDF15 in HD patients with malnutrition. The MIS together
with the GDF-15 level might be considered a combined
marker of the malnutrition/inflammation status and a
good predictor for mortality in HD patients especially in
the early period of malnutrition/inflammation.
GDF-15 is a stress-induced cytokine, and almost all
tissues can express GDF-15 in response to various forms of
stress [24]. It was recently reported that GDF15 activates
a receptor composed of a GFRAL and RET dimer. This
receptor group is specific to area postrema of the brain
stem that is responsible from anorexia, vomiting, and
nausea when it is activated [25]. Experimental data show
that lack of GFRAL is associated with elevated GDF-15 and

a decrease in food intake in mice [26]. Clinical data show
that, in healthy controls, GDF-15 is positively correlated
with the adiponectin level and negatively correlated with
BMI and body fat mass [27]. In HD patients, exposure
to multiple inflammatory agents, cardiac problems, and
uremia might all be related to increased cellular stress,
resulting in activation of GDF-15 and the nutrition axis.
In the present study, the GDF-15 level was significantly
higher in the patients with a high MIS. In addition, the
GDF-15 level was correlated with markers of nutrition and
inflammation, such as low albumin, low serum potassium,
and high CRP levels. GDF-15 was also more strongly
correlated with the MIS other than PNI and CONUT
score, but GDF-15 was not correlated with BMI or HD
vintage.
In literature, outcomes of GDF-15 and mortality studies
in HD patients are similar. In the latest study, Chang et
al. demonstrated that HD patients with older age, higher
plasma GDF-15 concentrations, and lower albumin levels
are more likely to have greater risks for all-cause death
[28]. In our final multivariate model, age, serum GDF-15,
and CRP were independent risk factors in line with the
literature. We also created a multivariate model combining
age and GDF-15 to find out the unified effect of age and
GDF-15 together. We found that both increase by 2.76
times significantly with increased age and high GDF-15
all-cause mortality. We think that this finding is valuable
particularly in elderly HD patients in whom it is already
difficult to obtain malnutrition/inflammation.
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Nakajima et al. analyzed GDF-15 in patients before
cardiovascular surgery and reported that the GDF-15 level
helps identify the risk of muscle wasting and renal dysfunction
before cardiovascular surgery [29]. Several mechanisms have
been suggested to be related to GDF-15 induced muscle
wasting [30]. As such, it is thought that an elevated GDF-15
level results in loss of appetite, anorexia, and cachexia, and
it directly affects muscle wasting and consequent weight loss
[30]. GDF-15 might be useful for the objective assessment of
malnutrition risk during the early period of HD, irrespective of
weight loss or prominent inflammation. The present findings
show that, according to MIS, the GDF-15 level significantly
differentiated malnutrition/inflammation with a cut-off 40.28
ng mL–1—this cut-off has not been previously reported. We
excluded patients with all obvious infectious states, known
cardiac problems, and inflammatory conditions to make
GDF-15 reliable in the assessment of malnutrition, but all
above finding needs to be confirmed by larger-scale studies.
There are some noteworthy limitations of this study.
Firstly, our study sample size was relatively small. Secondly,
cross-sectional laboratory values and GDF15 levels might
not reflect substantial intra-individual variability over time.
Finally, GDF-15 cut-off points might change because of
laboratory analysis techniques.
In conclusion, the assessment of nutritional status in HD
patients is complicated. The present findings indicate that

a high GDF-15 level is correlated with the MIS, even in
moderately malnourished HD patients. Early detection of
malnutrition/inflammation—before any marked cardiac
or metabolic complications occur—especially in the older
population could become the cornerstone for control
of nutritional problems in HD patients, but additional
research is required to confirm the present study’s findings.
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